Robert Spurr
CIK 1543795 · View on SEC EDGAR ↗
First SEC filing: June 1, 2020 · Latest: June 1, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 14, 2022 | BHC | S 10b5-1 | 1,595 | $22.19 | $35,393 | 90,506 Direct | -1.73% | Disposed | -68.3% (price as of 2026-08-19) |
| March 15, 2022 | BHC | S 10b5-1 | 4,846 | $22.20 | $107,581 | 92,101 Direct | -5.00% | Disposed | -68.4% (price as of 2026-08-19) |
| March 2, 2022 | BHC | S 10b5-1 | 1,595 | $23.37 | $37,275 | 65,394 Direct | -2.38% | Disposed | -69.9% (price as of 2026-08-19) |
| Feb. 15, 2022 | BHC | S 10b5-1 | 3,251 | $25.02 | $81,340 | 60,299 Direct | -5.12% | Disposed | -71.9% (price as of 2026-08-19) |
| Jan. 18, 2022 | BHC | S 10b5-1 | 3,251 | $26.63 | $86,574 | 63,550 Direct | -4.87% | Disposed | -73.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 10, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (0) | — | May 10, 2022 | 13,592 | Disposed |
| May 10, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (13,592) | — | May 10, 2022 | 13,592 | Acquired |
| May 10, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (0) | — | May 10, 2022 | 8,643 | Disposed |
| May 10, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (8,643) | — | May 10, 2022 | 8,643 | Acquired |
| March 2, 2022 | BHC | Non-Qualified Stock Options (right to purchase) | Common Shares, No Par Value (131,910) | $24.17 | March 2, 2032 | 131,910 | Acquired |
| Feb. 27, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (0) | $24.35 | Feb. 27, 2022 | 15,615 | Disposed |
| Feb. 27, 2022 | BHC | Restricted Share Units | Common Shares, No Par Value (15,615) | — | Feb. 27, 2022 | 15,615 | Acquired |
| Sept. 1, 2021 | BHC | Non-Qualified Stock Options (right to purchase) | Common Shares, No Par Value (31,400) | $28.85 | Sept. 1, 2031 | 31,400 | Acquired |
| March 3, 2021 | BHC | Non-qualified Stock Options (right To Purchase) | Common Shares, No Par Value (32,749) | $32.56 | March 3, 2031 | 32,749 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 1, 2020 | BHC | Common Shares, No Par Value | — | Direct |
| June 1, 2020 | BHC | Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (30,576) | 30,576 | Direct |
| June 1, 2020 | BHC | Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (39,863) | 39,863 | Direct |
| June 1, 2020 | BHC | Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (56,858) | 56,858 | Direct |
| March 12, 2012 | RGEN | Common Stock | 10,000 | Direct |
| March 12, 2012 | RGEN | Stock Option (Right to Purchase)→ Common Stock (100,000) | 100,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BHC
President US Pharmaceutical Business| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $336,538 | — | $861,105 | $874,563 | — | — | $2,230,891 | $4,303,097 |
| 2021 | $636,154 | — | — | — | $821,200 | — | $18,050 | $3,868,624 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.